Cargando…
The Suppression of Prolactin is required for the Treatment of Advanced Prostate Cancer
Androgen-independent advanced prostate cancer is a terminal malignancy that generally results in death within five years. Its cause has been unknown, and a treatment did not exist. Prevailing views have mistakenly implicated impaired androgen receptor activity in the development of androgen-independ...
Autor principal: | Costello, Leslie C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641560/ https://www.ncbi.nlm.nih.gov/pubmed/31328184 http://dx.doi.org/10.35702/onc.10013 |
Ejemplares similares
-
Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!
por: Costello, Leslie C., et al.
Publicado: (2018) -
A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and
Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal
Androgen-independent Prostate Cancer. Why and How?
por: Costello, Leslie C., et al.
Publicado: (2019) -
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots
por: Costello, Leslie C, et al.
Publicado: (2006) -
Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
por: Borcherding, Dana C., et al.
Publicado: (2021) -
Jak2 is required for the initiation but not maintenance of prolactin-induced mammary cancer
por: Sakamoto, Kazuhito, et al.
Publicado: (2010)